Peter Simpson
Peter Simpson Consulting Ltd
Peter is widely recognised as a strategic leader of life science companies, with a track record in driving innovation, growth, and impact. He is currently Chair of Dia Beta Labs Ltd, a peptide therapeutic-based SME in metabolic disease, and of Ephyra, a sponge RNA technology company, and he runs his life science consulting company Peter Simpson Consulting Ltd. He is passionate about building high performing teams that have an inclusive mindset, harnessing and developing a diverse range of talents to deliver strong outcomes. Peter was founding Chief Scientific Officer for Medicines Discovery Catapult, developing its research capabilities, teams and strategy. In the Covid pandemic, Peter led the establishment of one of UK’s 3 national Covid testing centres, which grew to employ 800 staff and delivered ~24 million Covid diagnostic tests. Peter has eighteen years of experience in developing successful drug discovery departments and programmes within major Pharmas (MSD, AstraZeneca).
Clare is a Chartered Scientist and Chemist with 20 years’ experience in the science community and not-for-profit sector. She is a member of the ELRIG early career professional (ECP) workgroup and is passionate about investing in future generations and those from diverse backgrounds and experiences, empowering people to realise their potential and achieve their career and development goals. Prior to her role at CRAC/Vitae, Clare was with the Royal Society of Chemistry (RSC) for 16 years in a variety of roles. CRAC is a charity and was founded in 1964. Vitae, non-profit programme of CRAC, is the global leader in supporting the career and professional development of researchers, experienced in working with governments and over 200 institutions in 23 countries. It strengthens members and partners provision through research and innovation, training and resources, events, consultancy and membership. Vitae advocates for a healthy research environment and culture that will attract and develop a more diverse workforce, believing this will impact positively on individual and institutional performance and bring societal and economic benefits.